Venture Capital Investors

Casdin Capital

venture capital firm Casdin Capital backs innovative tech ventures.

Venture Investor Overview

Venture Investor
Casdin Capital
Status
Active
Investor Type
Venture Capital
Activity Level
144 transactions
Funds Raised
Unknown
Industry Focus
Biopharmaceutical
Healthcare IT
Healthcare Services
Life Sciences
Medical Devices & Instruments

Contact Information

Contact
Eli Casdin
Title
Investment Director
Mailing Address
1350 Ave. of the Americas 1140
New York, NY 10019
USA
Phone
(212) 897-5430
Website
www.casdincapital.com
Email Address
[email protected]

Background Information

Overview
Casdin Capital, LLC is an investment firm focused on the life sciences and healthcare industry.
Profile
Casdin Capital LinkedIn Company Profile
Social Media
Casdin Capital Company Twitter Account
Company News
Casdin Capital News
Facebook
Casdin Capital on Facebook
YouTube
Casdin Capital on YouTube
Last Transaction
1/3/2024

Transaction History

Our records indicate that Casdin Capital invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Remix Therapeutics
1/3/2024
$60,000,000
Thyme Care
8/22/2023
$60,000,000
Octave Bioscience
7/26/2023
$30,000,000
Orbital Therapeutics
4/26/2023
$270,000,000
Function Oncology
4/12/2023
$28,000,000
Flare Therapeutics
3/22/2023
$123,000,000
Chroma Medicine
3/1/2023
$135,000,000
iVexSol
1/26/2023
$23,800,000
Nest Genomics
1/11/2023
$8,500,000
FogPharma
11/21/2022
$178,000,000
IDRx
8/2/2022
$122,000,000
Auron Therapeutics
7/20/2022
$48,000,000
Remix Therapeutics
5/18/2022
$70,000,000
Invetx
5/10/2022
$60,500,000
Moma Therapeutics
5/10/2022
$150,000,000
Celsius Therapeutics
3/24/2022
Unknown
Deepcell
3/22/2022
$73,000,000
Volta Labs
3/17/2022
$20,000,000
Creyon Bio
3/8/2022
$40,000,000
Kallyope
2/27/2022
$236,000,000
Ventus Therapeutics
2/18/2022
$140,000,000
Septerna
2/3/2022
$100,000,000
Leyden Labs
2/2/2022
$140,000,000
Xcell Biosciences
1/29/2022
$27,500,000
ONI
1/28/2022
$75,000,000
Verana Health
1/25/2022
$150,000,000
Maze Therapeutics
1/11/2022
$190,000,000
DNA Script
1/6/2022
$200,000,000
Apella
12/23/2021
$21,000,000
Exai Bio
12/10/2021
$67,500,000
Nomic
12/10/2021
$17,000,000
Chroma Medicine
11/18/2021
$125,000,000
Beacon Biosignals
11/9/2021
$27,000,000
DNA Script
10/28/2021
$165,000,000
Hexagon Bio
9/23/2021
$61,000,000
Rome Therapeutics
9/15/2021
$77,000,000
Vanqua Bio
9/15/2021
$85,000,000
Genome Medical
8/31/2021
$60,000,000
Sonoma Biotherapeutics
8/5/2021
$265,000,000
SeQure Dx
8/4/2021
$17,500,000
Genomatica
7/28/2021
$118,000,000
TMRW Life Sciences
7/21/2021
$105,000,000
Prime Medicine
7/14/2021
$200,000,000
Apton Biosystems
7/1/2021
$24,000,000
Umoja Biopharma
6/16/2021
$210,000,000
LetsGetChecked
6/9/2021
$150,000,000
Vedere Bio II
5/19/2021
$77,000,000
Dyno Therapeutics
5/7/2021
$100,000,000
Affinia Therapeutics
5/4/2021
$110,000,000
C2i Genomics
4/17/2021
$100,000,000
Multiply Labs
4/15/2021
$20,000,000
Ventus Therapeutics
4/9/2021
$100,000,000
Leyden Labs
3/25/2021
$47,000,000
Komodo Health
3/23/2021
$220,000,000
insitro
3/16/2021
$400,000,000
Monte Rosa Therapeutics
3/15/2021
$95,000,000
Amunix Pharmaceuticals
3/5/2021
$117,000,000
Century Therapeutics
3/4/2021
$160,000,000
Tenaya Therapeutics
3/2/2021
$106,000,000
FogPharma
3/2/2021
$107,000,000
Vividion Therapeutics
2/25/2021
$135,000,000
Notch Therapeutics
2/17/2021
$85,000,000
Pipeline Therapeutics
2/12/2021
$80,000,000
Verve Therapeutics
1/20/2021
$94,000,000
Paige.AI
1/18/2021
$100,000,000
Earli
1/13/2021
$40,000,000
Scorpion Therapeutics
1/8/2021
$162,000,000
SomaLogic
12/23/2020
$81,000,000
Octave Bioscience
12/21/2020
$32,000,000
Octave Bioscience
12/18/2020
$32,000,000
Neurogene
12/17/2020
$115,000,000
iVexSol
12/2/2020
$13,000,000
SomaLogic
11/26/2020
$121,000,000
Decibel Therapeutics
11/10/2020
$82,000,000
AbSci
10/21/2020
$65,000,000
Cedilla Therapeutics
10/14/2020
$57,600,000
Vineti
10/14/2020
$68,000,000
A2 Biotherapeutics
10/7/2020
$71,500,000
Invetx
10/1/2020
$10,250,000
Monte Rosa Therapeutics
9/25/2020
$96,000,000
Recursion Pharmaceuticals
9/10/2020
$239,000,000
Kronos Bio
8/26/2020
$155,000,000
Lyra Health
8/26/2020
$110,000,000
Tango Therapeutics
8/19/2020
$50,000,000
Taysha Gene Therapies
8/7/2020
$95,000,000
Thrive Earlier Detection
7/30/2020
$257,000,000
Cerevance
7/22/2020
$20,000,000
Genome Medical
7/2/2020
$14,000,000
Goldfinch Bio
7/1/2020
$100,000,000
4D Molecular Therapeutics
6/17/2020
$75,000,000
Verve Therapeutics
6/12/2020
$63,000,000
C2i Genomics
6/10/2020
$12,000,000
insitro
5/27/2020
$143,000,000
Moma Therapeutics
4/16/2020
$86,000,000
Tango Therapeutics
4/10/2020
$60,000,000
Kallyope
3/26/2020
$112,000,000
Amunix Pharmaceuticals
3/5/2020
$73,000,000
Vineti
2/6/2020
$35,000,000
Verana Health
2/6/2020
$100,000,000
Generation Bio
1/13/2020
$110,000,000
Black Diamond Therapeutics
12/6/2019
$85,000,000
Tenaya Therapeutics
10/4/2019
$92,000,000
Sexton Biotechnologies
9/25/2019
$5,000,000
Revolution Medicines
7/11/2019
$100,000,000
Genome Medical
6/12/2019
$23,000,000
Thrive Earlier Detection
5/31/2019
$110,000,000
Vividion Therapeutics
5/1/2019
$82,000,000
908 Devices
4/30/2019
$17,500,000
Maze Therapeutics
3/1/2019
$191,000,000
Relay Therapeutics
12/21/2018
$400,000,000
Genomatica
10/4/2018
$90,000,000
Prominex
9/14/2018
$4,000,000
Fulcrum Therapeutics
9/6/2018
$80,000,000
Alector
7/26/2018
$133,000,000
Celsius Therapeutics
5/16/2018
$65,000,000
Lyra Health
5/8/2018
$45,000,000
Revolution Medicines
4/25/2018
$56,000,000
Vineti
4/17/2018
$33,500,000
Magenta Therapeutics
4/10/2018
$52,000,000
Constellation Pharmaceuticals
4/10/2018
$100,000,000
Generation Bio
2/28/2018
$100,000,000
Relay Therapeutics
12/15/2017
$63,000,000
Neon Therapeutics
12/6/2017
$36,000,000
Codiak BioSciences
11/30/2017
$76,500,000
Arzeda
11/29/2017
$3,200,000
Magenta Therapeutics
5/3/2017
$50,000,000
908 Devices
3/16/2017
$20,000,000
Syros Pharmaceuticals
1/13/2016
$40,000,000
Flatiron Health
1/6/2016
$175,000,000
Gritstone Oncology
10/21/2015
$102,000,000
23andMe
10/14/2015
$115,000,000
Editas Medicine
8/10/2015
$120,000,000
908 Devices
7/1/2015
Unknown
CytomX Therapeutics
6/17/2015
$70,000,000
Adaptive Biotechnologies
5/6/2015
$195,000,000
MyoKardia
4/30/2015
$46,000,000
Jounce Therapeutics
4/23/2015
$56,000,000
Voyager Therapeutics
4/13/2015
$60,000,000
Blueprint Medicines
11/14/2014
$50,000,000
Invitae
10/13/2014
$120,000,000
Omicia
1/8/2014
$6,800,000
Blueprint Medicines
1/7/2014
$25,000,000
Invitae
12/12/2013
$40,000,000
Foundation Medicine
9/21/2012
$56,000,000

 

Investor Contacts

Title
Name
Email & Social
Investment Director
Eli Casdin
  Eli Casdin LinkedIn Profile  Eli Casdin Twitter Account  Eli Casdin News  Eli Casdin on Facebook

 

Funds

No fund closings have been recorded for this company.

 

Portfolio Companies

Casdin Capital has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
23andMe
4D Molecular Therapeutics
908 Devices
A2 Biotherapeutics
AbSci
Adaptive Biotechnologies
Affinia Therapeutics
Alector
Amunix Pharmaceuticals
Apella
Apton Biosystems
Arzeda
Auron Therapeutics
Beacon Biosignals
Black Diamond Therapeutics
Blueprint Medicines
C2i Genomics
Cedilla Therapeutics
Celsius Therapeutics
Century Therapeutics
Cerevance
Chroma Medicine
Codiak BioSciences
Constellation Pharmaceuticals
Creyon Bio
CytomX Therapeutics
Decibel Therapeutics
Deepcell
DNA Script
Dyno Therapeutics
Earli
Editas Medicine
Exai Bio
Flare Therapeutics
Flatiron Health
FogPharma
Foundation Medicine
Fulcrum Therapeutics
Function Oncology
Generation Bio
Genomatica
Genome Medical
Goldfinch Bio
Gritstone Oncology
Hexagon Bio
IDRx
insitro
Invetx
Invitae
iVexSol
Jounce Therapeutics
Kallyope
Komodo Health
Kronos Bio
LetsGetChecked
Leyden Labs
Lyra Health
Magenta Therapeutics
Maze Therapeutics
Moma Therapeutics
Monte Rosa Therapeutics
Multiply Labs
MyoKardia
Neon Therapeutics
Nest Genomics
Neurogene
Nomic
Notch Therapeutics
Octave Bioscience
Omicia
ONI
Orbital Therapeutics
Paige.AI
Pipeline Therapeutics
Prime Medicine
Prominex
Recursion Pharmaceuticals
Relay Therapeutics
Remix Therapeutics
Revolution Medicines
Rome Therapeutics
Scorpion Therapeutics
Septerna
SeQure Dx
Sexton Biotechnologies
SomaLogic
Sonoma Biotherapeutics
Syros Pharmaceuticals
Tango Therapeutics
Taysha Gene Therapies
Tenaya Therapeutics
Thrive Earlier Detection
Thyme Care
TMRW Life Sciences
Umoja Biopharma
Vanqua Bio
Vedere Bio II
Ventus Therapeutics
Verana Health
Verve Therapeutics
Vineti
Vividion Therapeutics
Volta Labs
Voyager Therapeutics
Xcell Biosciences

 

 

 

 

Browse more venture capital investors:

Cascador | CaseWorthy

 

Share this article

 

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.